Parenteral Drugs Market Overview
Parenteral Drugs Market was valued at US$ 490.5 Billion in 2024 and is projected to grow at a CAGR of 9.60% to reach US$ 1228 Billion by 2034.
Parenteral Drugs are the drugs given by route which is other than digestive tract by injection. Vaccines, insulin, antibiotics and opiod analgesics are some different examples of parenteral drugs.
Patient preference for injections over oral medication has contributed in market growth. Growing prevalence of diseases, effective properties of parenteral drugs and immediate relief as they are injected directly into vein in bloodstream has further driven the market growth. Growing strategic partnerships of companies and volume of drug approvals is expected to provide lucrative opportunities in Parenteral Drugs market growth in future.
Parenteral Drugs Market Dynamics
Growing investment in biological drugs and more approval of parenteral drugs to fuel market growth
Biological Drugs are made from living organisms to treat and diagnose the diseases. They include vaccines, interleukins and antibodies. Emerging pharmaceutical companies with lack of manufacturing facilities and growing need for biologics has powered the demand for contract manufacturing services which in turn fuel the target market growth. Further, more approvals for biologic drugs has provided lucrative opportunities in market growth. Contract Development Manufacturing Organizations (CDMO) are involved in production of parenteral drugs to reduce development timelines. Parenteral drug approval by FDA (Food and Drug Administration) and CDER (Center for Drug Evaluation and Research) has been increased over the last several years which has powered the market growth.
For instance, in 2022, FDA’s (Food and Drug Administration) Center for Drug Evaluation and Research (CDER) approved 28 novel drugs of 37 on first cycle. Mounjaro (tirzepatide) injection are used to improve glycemic control in people with type 2 diabetes disease. Pluvicto (lutetium 177 Lu vipiuvotide tetraxetan) injection used in treating prostate cancer in adults. Tzield (teplizumab-mzwv) injection is used to delay onset of stage 3 type 1 diabetes in pediatric and adult patients. Sunlenca (lenacapavir) injection and tablets are used for HIV patients.
Restrains:
However, huge investment required in manufacturing of parenteral drugs has hampered the demand for market growth. Further, risk of overdose and exposure to infection due to unsafe injection practices restrain the Parenteral Drugs Market growth.
Parenteral Drugs Market Segmentation
Parenteral Drugs Market is segmented based on Product Type, Route of Administration, Application, Distribution Channel and Region.
Product Type Insight
On the basis of Product Type, Parenteral Drugs Market is segmented into Insulin, Monoclonal Antibodies, Cytokines, Peptide Hormones and Others. Monoclonal Antibodies product type segment is expected to dominate the market growth. High number of product approvals by FDA (Food and Drug Administration) and expansion of product pipeline has boost the segment growth.
Route of Administration Insights
On the basis of Route of Administration, Parenteral Drugs Market is segmented into Subcutaneous, Intramuscular, Intravenous.
Application Insights
On the basis of Application, Parenteral Drugs Market is segmented into Oncology, Diabetes, Cardiovascular Diseases, Blood Disorders and Others. Oncology application segment is expected to dominate the target market growth. Growing prevalence of cancer diseases and use of parenteral drugs in oncology segment has boost the segment growth.
For instance, in 2020 according to CDC (Center for Disease Control and Prevention), around 1,603,844 new cancer cases were reported and about 602,347 of people were died of cancer diseases.
Distribution Channel Insights
On the basis of Distribution Channel, Parenteral Drugs Market is segmented into Hospital Pharmacies, Drug Stores, Online Pharmacies, Retail Pharmacies.
Regional Insights:
On region the Parenteral Drugs Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period. Moreover, rising prevalence of cancer disease, unhealthy diet, sedentary lifestyle, high disposable income, robust healthcare infrastructure, rising research & development activities, adoption of parenteral drugs is anticipated to increase demand for Parenteral Drugs in the region.
|
Attribute |
Details |
|
Base year for estimation |
2023 |
|
Forecast period |
2024 – 2034 |
|
Market representation |
Revenue in USD Billion & CAGR from 2024 to 2034 |
|
Market Segmentation |
By Product Type - Insulin, Monoclonal Antibodies, Cytokines, Peptide Hormones and Others By Route of Administration - Subcutaneous, Intramuscular, Intravenous By Application - Oncology, Diabetes, Cardiovascular Diseases, Blood Disorders and Others By Distribution Channel - Hospital Pharmacies, Drug Stores, Online Pharmacies, Retail Pharmacies |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the Parenteral Drugs Market report based on Product Type, Route of Administration, Application, Distribution Channel and Region:
Parenteral Drugs Market, By Product Type:
- Insulin
- Monoclonal Antibodies
- Cytokines
- Peptide Hormones
- Immunoglobulin
- Vaccines
- Blood Factors
- Chemotherapy Agents
- Small Molecule Antibiotics
- Peptide Antibiotics
- Others
Parenteral Drugs Market, By Route of Administration:
- Subcutaneous
- Intramuscular
- Intravenous
Parenteral Drugs Market, By Application:
- Oncology
- Diabetes
- Cardiovascular Diseases
- Blood Disorders
- Pain Management
- Hormonal Disorders
- Others
Parenteral Drugs Market, By Distribution Channel:
- Hospital Pharmacies
- Drug Stores
- Online Pharmacies
- Retail Pharmacies
Parenteral Drugs Market, By Region:
- North America
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
-
- U.S.
- Canada
- Middle East & Africa
Parenteral Drugs Market Key Players
The key players operating the Parenteral Drugs Market includes, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Pfizer Inc., Novartis AG, Sanofi S.A., Abbott, Beximco Pharma, Fresenius, Baxter Healthcare Corporation, Ostuka Pharmaceutical, and others.
Parenteral Drugs Market Company Profile
- Teva Pharmaceutical Industries Ltd.*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Merck & Co. Inc.
- Pfizer Inc.
- Novartis AG
- Sanofi S.A.
- Abbott
- Beximco Pharma
- Fresenius
- Baxter Healthcare Corporation
- Ostuka Pharmaceutical
“*” marked represents similar segmentation in other categories in the respective section
Recent Development:
- In March 2022, Otsuka obtained approval for its ‘SAMTASU’ in Japan. The new developed SAMTASU intravenous infusion used for treating cardiac edema and has become a new treatment option for patients with fluid retention.
- In September 2021, Baxter launched new ready to use cardiovascular medicine ‘Norepinephrine Bitartarate’ in 5% of Dextrose injection (norepinenephrine) used to raise blood pressure in patient with acute hypotension. Baxter new launched drug is available in United States.
- In August 2020, U.S. FDA (Food and Drug Administration) approved new ‘Kesimpta’ (ofatumumab) injection developed by Novartis for subcutaneous use for treating multiple sclerosis (RMS). The new launched Kesimpta is designed to be self-administered at home by patients once monthly by an autoinjector pen Sensoready.
Parenteral Drugs Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Preview
- Executive Summary
- Key Findings—Global Outlook for medical carts Strategies
- Key Questions this Study will Answer
- Market Snippet, By Product Type
- Market Snippet, By Route of Administration
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restrains
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Market Segmentation, By Product Type
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2024 – 2034
- Y-o-Y Growth Analysis (%), 2024 – 2034
- Segment Trends
- Insulin
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Monoclonal Antibodies
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Cytokines
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Peptide Hormones
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Overview
- Market Segmentation, By Route of Administration, 2024 – 2034, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2024 – 2034
- Y-o-Y Growth Analysis (%), 2024 – 2034
- Segment Trends
- Subcutaneous
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Intramuscular
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Intravenous
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Overview
- Market Segmentation, By Application, 2024 – 2034, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2024 – 2034
- Y-o-Y Growth Analysis (%), 2024 – 2034
- Segment Trends
- Oncology
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Diabetes
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Cardiovascular Diseases
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Blood Disorders
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Overview
- Market Segmentation, By Distribution Channel, 2024 – 2034, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2024 – 2034
- Y-o-Y Growth Analysis (%), 2024 – 2034
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Drug Stores
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Online Pharmacies
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Retail Pharmacies
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Overview
- Global Market, By Region, 2024 – 2034, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2024 – 2034
- Y-o-Y Growth Analysis (%), 2024 – 2034
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Product Type, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Route of Administration, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Application, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Distribution Channel, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Country, 2024 – 2034
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Product Type, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Route of Administration, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Application, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Distribution Channel, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Country, 2024 – 2034
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Product Type, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Route of Administration, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Application, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Distribution Channel, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Country, 2024 – 2034
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Product Type, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Route of Administration, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Application, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Distribution Channel, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Country, 2024 – 2034
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Product Type, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Route of Administration, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Application, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Distribution Channel, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Country, 2024 – 2034
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Merck & Co. Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Sanofi S.A.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Abbott
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Beximco Pharma
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Fresenius
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Baxter Healthcare Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Ostuka Pharmaceutical
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The Parenteral Drugs Market is segmented into Product Type, Route of Administration, Application, Distribution Channel and Region.
Parenteral Drugs Market is driven by factors like growing investment in biologic drugs and more approval of parenteral drugs.
By region, the Parenteral Drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period.
The key players operating the Parenteral Drugs Market includes, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Pfizer Inc., Novartis AG, Sanofi S.A., Abbott, Beximco Pharma, Fresenius, Baxter Healthcare Corporation, Ostuka Pharmaceutical, and others.